Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharmaceutical Receives EMA Support For Cancer Drug Application
Sun received the recommendations in concurrence with the Sanofi-Aventis’s suit in the US against it, claiming that it is a case of infringement of patent and asking the
Sun received the recommendations in concurrence with the Sanofi-Aventis’s suit in the US against it, claiming that it is a case of infringement of patent and asking the
Pegsitacase metabolises poorly soluble uric acid into highly soluble allantoin, thus lowering uric acid levels, and its long half-life may provide for an extended duration of uric acid-lowering
The companies said that the agreement includes an upfront fee and potential milestones totaling over $200m as well as product royalties. Lauren Silverman, managing director of Novartis Option
CM-AT is based on Dr Fallon’s research that showed enzyme deficiencies in autistic children, resulting in an inability to digest protein. The inability to digest protein affects the
The company claims that Coenzyme-A is energy pure and simple. Besides its indispensable energy work, Coenzyme-A initiates the synthesis of a variety of other essential substances. These include
The company said that the approval comes after extensive testing and auditing of the Amcor facilities, which have already begun to package the Catrix Wound Dressing. All regulatory
The Metabolism and Pharmacokinetics group at Charles River, has been conducting radiolabelled trials in man for more than 20 years. The facility includes a GMP clean room, licensed
Investors in the Series D round included Commonwealth Capital Ventures, FLIR Systems, Rock Maple Ventures, Life Sciences Partners, Oxford Bioscience Partners, Healthcare Ventures, New Science Ventures and HLM
Under the collaboration, the organisations intend to initially develop and manufacture vaccines for flu, dengue fever and West Nile virus. Phillip Frost, chairman and CEO of Opko, said:
Haemonetics’ Cymbal is a small, portable, battery operated instrument that automates blood collection from volunteer donors, improving process control and helping alleviate blood shortages. The expanded nomogram is